Physician profile
Kristina Janea Warner
NPI 1346695509
$8,159.50
in general payments reported to CMS, 2019-2025
8 companies · $4,834 in 2025
The $4,834 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2021: $20.87 · 2022: $16.14 · 2023: $121 · 2024: $3,037 · 2025: $4,834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,646 · Education: $3,183 · Food and Beverage: $1,162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,645.83 |
| Education | $3,182.62 |
| Food and Beverage | $1,162.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,000.00 | 2025 | |
| Axonics, INC. | $2,107.97 | 2023-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $1,943.98 | 2023-2025 | Solyx Sis System, General - Female Sui, Upsylon |
| Medtronic, INC. | $804.95 | 2022-2024 | Interstim |
| Medtronic USA, INC. | $131.73 | 2019 | |
| Coopersurgical, INC. | $125.00 | 2025 | Ally II Ups |
| Femselect INC. | $25.00 | 2024 | Enplace |
| Astellas Pharma US INC | $20.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristina Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.